Keyphrases
Acute Myeloid Leukemia
100%
Drug Target
100%
CD34+ Cells
100%
Gene Expression Profiling
100%
Early Gene Expression
100%
AML1-ETO
100%
Fusion Oncogene
100%
In Vitro Transformation
100%
Murine Double Minute 2 (MDM2)
60%
PML-RARA
60%
Gene Deregulation
60%
MLL-AF9
40%
Self-renewal
40%
NUP98-HOXA9
40%
Putative Drug Targets
20%
Cell Transformation
20%
Oncogene
20%
Myeloid Differentiation
20%
In Vitro Effect
20%
P53 Inhibitor
20%
Clinical Features
20%
Malignant Transformation
20%
Temporal Patterns
20%
Laboratory Features
20%
Erythroid Maturation
20%
Erythroid Differentiation
20%
Nutlin-3
20%
Myeloid Maturation
20%
Clinical Similarity
20%
Erythroid Hyperplasia
20%
Neuroscience
Myeloid
100%
CD34
100%
In Vitro
100%
Gene Expression
100%
Gene Fusion
100%
Polymorphonuclear Cell
42%
P53
28%
HOXA9
28%
Oncogene
14%
Cell Transformation
14%
Hyperplasia
14%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
In Vitro
100%
Gene Expression Profiling
100%
Gene Fusion
100%
Granulocyte
60%
Protein P53
40%
Upregulation
20%
Oncogene
20%
Hyperplasia
20%
Malignant Transformation
20%
Cell Transformation
20%
Nutlin 3
20%
Maturation
20%
Biochemistry, Genetics and Molecular Biology
Gene Expression Profiling
100%
Myeloid
100%
CD34
100%
Gene Fusion
100%
Polymorphonuclear Cell
42%
NUP98
28%
HOXA9
28%
P53
28%
Oncogene
14%
Nutlin
14%
Maturation
14%
Cell Transformation
14%
Upregulation
14%
Malignant Transformation
14%
Immunology and Microbiology
Myeloid
100%
CD34
100%
Gene Fusion
100%
Gene Expression Assay
100%
Granulocyte
42%
P53
28%
Maturation
14%
Cell Transformation
14%
Upregulation
14%
Oncogene
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Protein P53
40%
Nutlin 3
20%
Hyperplasia
20%
Malignant Transformation
20%